Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Indivior Pharmaceuticals (INDV) Tax Rate (2022 - 2026)

Indivior Pharmaceuticals has reported Tax Rate over the past 5 years, most recently at 22.61% for Q1 2026.

  • For Q1 2026, Tax Rate rose 396.0% year-over-year to 22.61%; the TTM value through Mar 2026 reached 14.92%, down 20175.0%, while the annual FY2025 figure was 12.13%, 5287.0% down from the prior year.
  • Tax Rate for Q1 2026 was 22.61% at Indivior Pharmaceuticals, up from 25.93% in the prior quarter.
  • Over five years, Tax Rate peaked at 70.97% in Q2 2025 and troughed at 37.1% in Q2 2023.
  • A 5-year average of 0.64% and a median of 12.49% in 2025 define the central range for Tax Rate.
  • Biggest five-year swings in Tax Rate: soared 5621bps in 2024 and later tumbled -7066bps in 2025.
  • Year by year, Tax Rate stood at 28.52% in 2022, then soared by 60bps to 11.48% in 2023, then soared by 490bps to 44.74% in 2024, then crashed by -158bps to 25.93% in 2025, then soared by 187bps to 22.61% in 2026.
  • Business Quant data shows Tax Rate for INDV at 22.61% in Q1 2026, 25.93% in Q4 2025, and 13.51% in Q3 2025.